Fast Five Quiz: Interstitial Lung Disease Progressive Fibrosing Management

Zab Mosenifar, MD


February 01, 2022

Patients with PF-ILD have generally been treated with either antifibrotic therapy for IPF or immunosuppressive therapy for non-IPF ILD. Recent clinical trial data have shown the efficacy of antifibrotic therapy in PF-ILD, and combined antifibrotic and immunosuppressant therapy may address both the fibrotic and inflammatory components of ILD.

Learn more about medication for PF-ILD.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.